The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Phage therapy: Facts and fiction
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phages and the Evolution of Bacterial Pathogens: from Genomic Rearrangements to Lysogenic Conversion
Brüssow, H., Canchaya, C., & Hardt, W.-D. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.3.560-602.2004 · Cited by 1,725
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Ultrastructure of bacteriophage and bacteriocins
Bradley, D. (1967) · Bacteriological Reviews · doi:10.1128/br.31.4.230-314.1967 · Cited by 867
Standard reference strains of Escherichia coli from natural populations
Ochman, H., & Selander, R. K. (1984) · Journal of Bacteriology · doi:10.1128/jb.157.2.690-693.1984 · Cited by 807
A bacteriolytic agent that detects and kills Bacillus anthracis
Schuch, R., Nelson, D., & Fischetti, V. A. (2002) · Nature · doi:10.1038/nature01026 · Cited by 656
Nelson, D., Loomis, L., & Fischetti, V. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061038398 · Cited by 578
Smith, H. W., & Huggins, M. B. (1982) · Microbiology · doi:10.1099/00221287-128-2-307 · Cited by 518
Rapid Killing of Streptococcus pneumoniae with a Bacteriophage Cell Wall Hydrolase
Loeffler, J. M., Nelson, D., & Fischetti, V. A. (2001) · Science · doi:10.1126/science.1066869 · Cited by 517
Long-circulating bacteriophage as antibacterial agents.
Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., & Adhya, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3188 · Cited by 512
Population and evolutionary dynamics of phage therapy
Levin, B. R., & Bull, J. J. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro822 · Cited by 511
Summers, W. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.437 · Cited by 474
Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A. N., Powell, B., Carlton, R., & Merril, C. R. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.204-210.2002 · Cited by 467
Smith, H. W., & Huggins, M. B. (1983) · Microbiology · doi:10.1099/00221287-129-8-2659 · Cited by 436
The prospect for bacteriophage therapy in Western medicine
Merril, C. R., Scholl, D., & Adhya, S. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1111 · Cited by 367
The Control of Experimental Escherichia coli Diarrhoea in Calves by Means of Bacteriophages
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1111 · Cited by 365
Bacteriophages show promise as antimicrobial agents
Alisky, J., Iczkowski, K., Rapoport, A., & Troitsky, N. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)92874-2 · Cited by 318
Bacteriophage therapy of infectious diseases in aquaculture
Nakai, T., & Park, S. C. (2002) · Research in Microbiology · doi:10.1016/s0923-2508(01)01280-3 · Cited by 276
Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia
Loeffler, J. M., Djurkovic, S., & Fischetti, V. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.11.6199-6204.2003 · Cited by 269
Matsuzaki, S., Yasuda, M., Nishikawa, H., Kuroda, M., Ujihara, T., Shuin, T., Shen, Y., Jin, Z., Fujimoto, S., Nasimuzzaman, M. D., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/374001 · Cited by 260
Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S., & Brüssow, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2558-2569.2004 · Cited by 234
Cheng, Q., Nelson, D., Zhu, S., & Fischetti, V. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.111-117.2005 · Cited by 233
Understanding Bacteriophage Therapy as a Density-dependent Kinetic Process
PAYNE, R. J. H., & JANSEN, V. A. A. (2001) · Journal of Theoretical Biology · doi:10.1006/jtbi.2000.2198 · Cited by 233
The genome of bacteriophage φKZ of Pseudomonas aeruginosa
Mesyanzhinov, V. V., Robben, J., Grymonprez, B., Kostyuchenko, V. A., Bourkaltseva, M. V., Sykilinda, N. N., Krylov, V. N., & Volckaert, G. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5396 · Cited by 229
Pajunen, M., Kiljunen, S., & Skurnik, M. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.18.5114-5120.2000 · Cited by 226
Self-citationOvercoming the Phage Replication Threshold: a Mathematical Model with Implications for Phage Therapy
Kasman, L. M., Kasman, A., Westwater, C., Dolan, J., Schmidt, M. G., & Norris, J. S. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5557-5564.2002 · Cited by 221
Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals
Payne, R. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109520 · Cited by 216
Jado, I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg485 · Cited by 216
Westwater, C., Kasman, L. M., Schofield, D. A., Werner, P. A., Dolan, J. W., Schmidt, M. G., & Norris, J. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1301-1307.2003 · Cited by 214
Pharmacokinetic Principles of Bacteriophage Therapy
Payne, R. J. H., & Jansen, V. A. A. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00002 · Cited by 207
Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage
Hagens, S., Habel, A., von Ahsen, U., von Gabain, A., & Bläsi, U. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3817-3822.2004 · Cited by 187
Bacteriophage and the Toxigenicity of Clostridium botulinum Type C
Eklund, M. W., Poysky, F. T., Reed, S. M., & Smith, C. A. (1971) · Science · doi:10.1126/science.172.3982.480 · Cited by 186
Phage Therapy of Local and Systemic Disease Caused by Vibrio vulnificus in Iron-Dextran-Treated Mice
Cerveny, K. E., DePaola, A., Duckworth, D. H., & Gulig, P. A. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6251-6262.2002 · Cited by 179
Bacteriophage control of Pseudomonas plecoglossicida infection in ayu, Plectoglossis altivelis
Park, S., & Nakai, T. (2003) · Diseases of Aquatic Organisms · doi:10.3354/dao053033 · Cited by 167
Broxmeyer, L., Sosnowska, D., Miltner, E., Chacón, O., Wagner, D., McGarvey, J., Barletta, R. G., & Bermudez, L. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/343812 · Cited by 160
Prevention of Escherichia coli infection in broiler chickens with a bacteriophage aerosol spray
HUFF, W. E., Huff, G. R., Rath, N., Balog, J., & Donoghue, A. (2002) · Poultry Science · doi:10.1093/ps/81.10.1486 · Cited by 153
Loeffler, J. M., & Fischetti, V. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.375-377.2003 · Cited by 143
HUFF, W. E., Huff, G. R., Rath, N. C., BALOG, J. M., & Donoghue, A. M. (2004) · Poultry Science · doi:10.1093/ps/83.12.1944 · Cited by 142
Prevention of Escherichia coli Respiratory Infection in Broiler Chickens with Bacteriophage (SPR02)
HUFF, W. E., Huff, G. R., Rath, N. C., BALOG, J. M., Xie, H., Moore, P., & Donoghue, A. M. (2002) · Poultry Science · doi:10.1093/ps/81.4.437 · Cited by 141
Skurnik, M., Venho, R., Toivanen, P., & Al-Hendy, A. A. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.mmi_17030575.x · Cited by 130
Self-citationPhage therapy—advantages over antibiotics?
Pirisi, A. (2000) · The Lancet · doi:10.1016/s0140-6736(05)74059-9 · Cited by 130
Phage therapy: a reappraisal of bacteriophages as antibiotics.
Inal, J. M. (2003) · PubMed · Cited by 130
Dynamics of success and failure in phage and antibiotic therapy in experimental infections
Bull, J. J., Levin, B. R., DeRouin, T., Walker, N., & Bloch, C. A. (2002) · BMC Microbiology · doi:10.1186/1471-2180-2-35 · Cited by 127
Djurkovic, S., Loeffler, J. M., & Fischetti, V. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1225-1228.2005 · Cited by 114
Skurnik, M., Venho, R., Bengoechea, J. A., & Moriyón, I. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01285.x · Cited by 109
Self-citationDuckworth, D. H., & Gulig, P. A. (2002) · BioDrugs · doi:10.2165/00063030-200216010-00006 · Cited by 108
Brahams, D. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92844-7 · Cited by 97
Skurnik, M. (1984) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1984.tb01362.x · Cited by 93
Self-citationCharacterization of a Shiga Toxin-Encoding Temperate Bacteriophage of Shigella sonnei
Strauch, E., Lurz, R., & Beutin, L. (2001) · Infection and Immunity · doi:10.1128/iai.69.12.7588-7595.2001 · Cited by 90
Self-citationBacterial viruses as human vaccines?
Clark, J. R., & March, J. B. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.4.463 · Cited by 89
Beutin, L., Strauch, E., & Fischer, I. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00961-7 · Cited by 78
Self-citationProjan, S. J. (2004) · Nature Biotechnology · doi:10.1038/nbt0204-167 · Cited by 55
Pelkonen, S., Aalto, J., & Finne, J. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.23.7757-7761.1992 · Cited by 47
Phage offer a real alternative
Schoolnik, G. K., Summers, W. C., & Watson, J. D. (2004) · Nature Biotechnology · doi:10.1038/nbt0504-505 · Cited by 27
Dixon, B. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00951-x · Cited by 23
Cited by
Pros and cons of phage therapy
Loc-Carrillo, C., & Abedon, S. T. (2011) · Bacteriophage · doi:10.4161/bact.1.2.14590 · Cited by 1,020
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth
Hyman, P. (2019) · Pharmaceuticals · doi:10.3390/ph12010035 · Cited by 546
Antibiotic Adjuvants: Diverse Strategies for Controlling Drug‐Resistant Pathogens
Gill, E. E., Franco, O. L., & Hancock, R. E. W. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12478 · Cited by 319
Biotechnological applications of bacteriophages: State of the art
Harada, L. K., Silva, E. C., Campos, W. F., Del Fiol, F. S., Vila, M., Dąbrowska, K., Krylov, V. N., & Balcão, V. M. (2018) · Microbiological Research · doi:10.1016/j.micres.2018.04.007 · Cited by 318
Metadata
- Authors
- Skurnik, M., & Strauch, E.
- Venue
- International Journal of Medical Microbiology
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 296
- Issue
- 1
- Pages
- 5-14
- ISSN
- 1438-4221 (ISSN-L)
- OpenAlex
- W1997078650
- Cited by
- 296
- References
- 54
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.